B-Cell Malignancies: The Use of Small Molecule Agents for Treatment and Management
作者: Barbara B. Rogers
刊名: Clinical Journal of Oncology Nursing, 2020, Vol.24 (2)
来源数据库: Oncology Nursing Society
DOI: 10.1188/20.CJON.199-204
关键词: B-cell malignanciesAdverse eventsSmall molecule agentsHematologic malignancies
原始语种摘要: Hematologic B-cell malignancies, which have varying behavior patterns, disease processes, and treatment responses, include non-Hodgkin lymphoma, leukemias, and myeloma. Although monoclonal antibodies and other agents have led to dramatic advances in the treatment of B-cell malignancies, the development of small molecules have enhanced the ability to treat and manage these malignancies and their adverse events (AEs). Oncology nurses need to be educated on the unique side effects for each class of these agents so that they can administer interventions to prevent and manage AEs in patients.
全文获取路径: PDF下载  ONS 
影响因子:0.91 (2012)

  • treatment 处理
  • advances 预付款
  • these 这些的
  • events 定时
  • effects 海员自身物品
  • administer 管理
  • manage 驾驶
  • enhanced 增强
  • their 他们的
  • monoclonal 单细胞系的